These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment of hypertension in renal failure patients: when do we overtreat? When do we undertreat? Rosansky SJ Blood Purif; 1996; 14(4):315-20. PubMed ID: 8873957 [TBL] [Abstract][Full Text] [Related]
7. Left ventricular hypertrophy is a risk factor independent of hypertension in survival of hemodialyzed patients. Nakamura S; Sasaki O; Nakahama H; Inenaga T; Kimura G Ren Fail; 2002 Mar; 24(2):175-86. PubMed ID: 12071591 [TBL] [Abstract][Full Text] [Related]
8. Common medical conditions in elderly dental patients. Part one: cardiovascular implications and management. Grover S; Rhodus NL Northwest Dent; 2012; 91(5):29-35. PubMed ID: 23155840 [No Abstract] [Full Text] [Related]
10. Left ventricular hypertrophy, ischemic heart disease and the incidence of cardiovascular events in Japanese high-risk hypertensive patients. Seto S Circ J; 2009 Jun; 73(6):1014-5. PubMed ID: 19465782 [No Abstract] [Full Text] [Related]
11. Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Ansari A; Kaupke CJ; Vaziri ND; Miller R; Barbari A Int J Artif Organs; 1993 Jan; 16(1):31-6. PubMed ID: 8458668 [TBL] [Abstract][Full Text] [Related]
12. Options in dialysis therapy: significance of cardiovascular findings. Wizemann V; Timio M; Alpert MA; Kramer W Kidney Int Suppl; 1993 Feb; 40():S85-91. PubMed ID: 8445844 [TBL] [Abstract][Full Text] [Related]
13. Interplay of volume, blood pressure, organ ischemia, residual renal function, and diet: certainties and uncertainties with dialytic management. Ok E; Levin NW; Asci G; Chazot C; Toz H; Ozkahya M Semin Dial; 2017 Sep; 30(5):420-429. PubMed ID: 28581677 [TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular diseases in patients with chronic renal diseases]. Dimković N Srp Arh Celok Lek; 2008 May; 136 Suppl 2():135-41. PubMed ID: 18924484 [TBL] [Abstract][Full Text] [Related]
15. [The treatment of ischemic heart disease in patients with chronic kidney failure]. Diadyk AI; Bagriĭ AE; Stulikova EL Lik Sprava; 1998 Jun; (4):42-5. PubMed ID: 9784699 [No Abstract] [Full Text] [Related]
16. ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure. Dyadyk AI; Bagriy AE; Lebed IA; Yarovaya NF; Schukina EV; Taradin GG Nephrol Dial Transplant; 1997 May; 12(5):945-51. PubMed ID: 9175047 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of left ventricular hypertrophy in dialysis patients. London GM; Guerin AP; Marchais SJ Blood Purif; 1994; 12(4-5):277-83. PubMed ID: 7865187 [TBL] [Abstract][Full Text] [Related]
19. Influence of hypertension on cardiovascular outcomes in hemodialysis patients. Birchem JA; Fraley MA; Senkottaiyan N; Alpert MA Semin Dial; 2005; 18(5):391-5. PubMed ID: 16191179 [TBL] [Abstract][Full Text] [Related]
20. Morbidity and mortality due to hypertension in patients with renal failure. Ritz E; Koch M Am J Kidney Dis; 1993 May; 21(5 Suppl 2):113-8. PubMed ID: 8494009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]